1. Changes in ctDNA levels established with the untargeted mFAST-SeqS method reflect response to therapy in metastasized breast cancer patients. (July 2016) Authors: Heitzer, E.; Auer, M.; Suppan, C.; Dandachi, N.; Balic, M. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Extended adjuvant treatment of patients with HER2+ early breast cancer with neratinib: a multi-centric, prospective, non-interventional study (NIS) in Germany and Austria (ELEANOR). (April 2021) Authors: Bartsch, R.; Lüftner, D.; Balic, M.; Rinnerthaler, G.; Jackisch, C.; Müller, V.; Schmidt, M.; Harbeck, N. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0270 Antihormones with or without irradiation in breast cancer: 10-year results of the ABCSG 8A trial. (April 2019) Authors: Fastner, G.; Sedlmayer, F.; Widder, J.; Metz, M.; Geinitz, H.; Kapp, K.; Sölkner, L.; Greil, R.; Jakesz, R.; Kwasny, W.; Heck, D.; Bjelic-Radisic, V.; Balic, M.; Stöger, H.; Wieder, U.; Zwrtek, R.; Semmler, D.; Horvath, W.; Melbinger-Zeinitzer, E.; Wiesholzer, M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib. (April 2023) Authors: Bartsch, R.; Harbeck, N.; Wrobel, D.; Zaiss, M.; Terhaag, J.; Guth, D.; Distelrath, A.; Wuerstlein, R.; Zahn, M.-O.; Lüftner, D.; Schwitter, M.; Balic, M.; Jackisch, C.; Müller, V.; Rinnerthaler, G.; Schmidt, M.; Zaman, K.; Schinköthe, T.; Gorray, M.; Breitenstein, U. Journal: Breast Issue: Volume 68(2023) Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?. (April 2023) Authors: Wimmer, K.; Hlauschek, D.; Balic, M.; Pfeiler, G.; Strobl-Kacerovsky, S.; Greil, R.; Singer, C.F.; Halper, S.; Steger, G.; Suppan, C.; Gampenrieder, S.P.; Helfgott, R.; Egle, D.; Filipits, M.; Jakesz, R.; Sölkner, L.; Fesl, C.; Gnant, M.; Fitzal, F. Journal: Breast Issue: Volume 68(2023)Supplement Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment. (April 2018) Authors: Suppan, C.; Brcic, I.; Heitzer, E.; Tiran, V.; Mueller, H.D.; Auer, M.; Cote, R.J.; Datar, R.; Dandachi, N.; Balic, M. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Serial blood draws in metastatic breast cancer patients undergoing systemic treatment analysed by size based CTC detection and mFAST Seq cell free DNA analysis. (February 2017) Authors: Suppan, C.; Tiran, V.; Heitzer, E.; Auer, M.; Cote, R.J.; Datar, R.H.; Dandachi, N.; Balic, M. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗